Review




Structured Review

ProMIS Neurosciences promis® physical function short form 20a
Anchor-based MCIDs for 6MWD (% predicted) for subgroups of patients with baseline 6MWD < 150 m, < 300 m, < 400 m, < 450 m, and ≥ 450 m. Abbreviations: 6MWD 6-min walk distance, m meter, FVC forced vital capacity, FVC ≥ 3% MCID based on patients with an FVC (% predicted) change from baseline of ≥ 3% at Week 52, MCID minimal clinically important difference, PROMIS Patient-Reported Outcome Measures Information System, PROMIS ≥ 0 MCID based on patients with a PROMIS Physical Function short form <t>20a</t> (PF) change from baseline of ≥ 0 points at Week 52, PROMIS ≥ 2 MCID based on patients with a PROMIS PF change from baseline of ≥ 2 points at Week 52, PROMIS ≥ 4 MCID based on patients with a PROMIS PF change from baseline of ≥ 4 points at Week 52, SGIC Subject’s Global Impression of Change, SGIC ≥ 4 MCID based on patients with an SGIC of ≥ 4 points at Week 52, SGIC ≥ 5 MCID based on patients with an SGIC of ≥ 5 points at Week 52, SGIC = 4 MCID based on patients with an SGIC of = 4 points at Week 52, SGIC = 5 MCID based on patients with an SGIC of = 5 points
Promis® Physical Function Short Form 20a, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/promis%C2%AE+physical+function+short+form+20a/pmc11008008-87-39-47?v=ProMIS+Neurosciences
Average 90 stars, based on 1 article reviews
promis® physical function short form 20a - by Bioz Stars, 2026-08
90/100 stars

Images

1) Product Images from "Minimal clinically important differences in six-minute walking distance in late-onset Pompe disease"

Article Title: Minimal clinically important differences in six-minute walking distance in late-onset Pompe disease

Journal: Orphanet Journal of Rare Diseases

doi: 10.1186/s13023-024-03156-3

Anchor-based MCIDs for 6MWD (% predicted) for subgroups of patients with baseline 6MWD < 150 m, < 300 m, < 400 m, < 450 m, and ≥ 450 m. Abbreviations: 6MWD 6-min walk distance, m meter, FVC forced vital capacity, FVC ≥ 3% MCID based on patients with an FVC (% predicted) change from baseline of ≥ 3% at Week 52, MCID minimal clinically important difference, PROMIS Patient-Reported Outcome Measures Information System, PROMIS ≥ 0 MCID based on patients with a PROMIS Physical Function short form 20a (PF) change from baseline of ≥ 0 points at Week 52, PROMIS ≥ 2 MCID based on patients with a PROMIS PF change from baseline of ≥ 2 points at Week 52, PROMIS ≥ 4 MCID based on patients with a PROMIS PF change from baseline of ≥ 4 points at Week 52, SGIC Subject’s Global Impression of Change, SGIC ≥ 4 MCID based on patients with an SGIC of ≥ 4 points at Week 52, SGIC ≥ 5 MCID based on patients with an SGIC of ≥ 5 points at Week 52, SGIC = 4 MCID based on patients with an SGIC of = 4 points at Week 52, SGIC = 5 MCID based on patients with an SGIC of = 5 points
Figure Legend Snippet: Anchor-based MCIDs for 6MWD (% predicted) for subgroups of patients with baseline 6MWD < 150 m, < 300 m, < 400 m, < 450 m, and ≥ 450 m. Abbreviations: 6MWD 6-min walk distance, m meter, FVC forced vital capacity, FVC ≥ 3% MCID based on patients with an FVC (% predicted) change from baseline of ≥ 3% at Week 52, MCID minimal clinically important difference, PROMIS Patient-Reported Outcome Measures Information System, PROMIS ≥ 0 MCID based on patients with a PROMIS Physical Function short form 20a (PF) change from baseline of ≥ 0 points at Week 52, PROMIS ≥ 2 MCID based on patients with a PROMIS PF change from baseline of ≥ 2 points at Week 52, PROMIS ≥ 4 MCID based on patients with a PROMIS PF change from baseline of ≥ 4 points at Week 52, SGIC Subject’s Global Impression of Change, SGIC ≥ 4 MCID based on patients with an SGIC of ≥ 4 points at Week 52, SGIC ≥ 5 MCID based on patients with an SGIC of ≥ 5 points at Week 52, SGIC = 4 MCID based on patients with an SGIC of = 4 points at Week 52, SGIC = 5 MCID based on patients with an SGIC of = 5 points

Techniques Used:



Similar Products

90
ProMIS Neurosciences promis® physical function short form 20a
Anchor-based MCIDs for 6MWD (% predicted) for subgroups of patients with baseline 6MWD < 150 m, < 300 m, < 400 m, < 450 m, and ≥ 450 m. Abbreviations: 6MWD 6-min walk distance, m meter, FVC forced vital capacity, FVC ≥ 3% MCID based on patients with an FVC (% predicted) change from baseline of ≥ 3% at Week 52, MCID minimal clinically important difference, PROMIS Patient-Reported Outcome Measures Information System, PROMIS ≥ 0 MCID based on patients with a PROMIS Physical Function short form <t>20a</t> (PF) change from baseline of ≥ 0 points at Week 52, PROMIS ≥ 2 MCID based on patients with a PROMIS PF change from baseline of ≥ 2 points at Week 52, PROMIS ≥ 4 MCID based on patients with a PROMIS PF change from baseline of ≥ 4 points at Week 52, SGIC Subject’s Global Impression of Change, SGIC ≥ 4 MCID based on patients with an SGIC of ≥ 4 points at Week 52, SGIC ≥ 5 MCID based on patients with an SGIC of ≥ 5 points at Week 52, SGIC = 4 MCID based on patients with an SGIC of = 4 points at Week 52, SGIC = 5 MCID based on patients with an SGIC of = 5 points
Promis® Physical Function Short Form 20a, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/promis%C2%AE+physical+function+short+form+20a/pmc11008008-87-39-47?v=ProMIS+Neurosciences
Average 90 stars, based on 1 article reviews
promis® physical function short form 20a - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
ProMIS Neurosciences promis— physical function—short form 20a
Anchor-based MCIDs for 6MWD (% predicted) for subgroups of patients with baseline 6MWD < 150 m, < 300 m, < 400 m, < 450 m, and ≥ 450 m. Abbreviations: 6MWD 6-min walk distance, m meter, FVC forced vital capacity, FVC ≥ 3% MCID based on patients with an FVC (% predicted) change from baseline of ≥ 3% at Week 52, MCID minimal clinically important difference, PROMIS Patient-Reported Outcome Measures Information System, PROMIS ≥ 0 MCID based on patients with a PROMIS Physical Function short form <t>20a</t> (PF) change from baseline of ≥ 0 points at Week 52, PROMIS ≥ 2 MCID based on patients with a PROMIS PF change from baseline of ≥ 2 points at Week 52, PROMIS ≥ 4 MCID based on patients with a PROMIS PF change from baseline of ≥ 4 points at Week 52, SGIC Subject’s Global Impression of Change, SGIC ≥ 4 MCID based on patients with an SGIC of ≥ 4 points at Week 52, SGIC ≥ 5 MCID based on patients with an SGIC of ≥ 5 points at Week 52, SGIC = 4 MCID based on patients with an SGIC of = 4 points at Week 52, SGIC = 5 MCID based on patients with an SGIC of = 5 points
Promis— Physical Function—Short Form 20a, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/promis%C2%AE+physical+function+short+form+20a/pm35441200-158-5-7?v=ProMIS+Neurosciences
Average 90 stars, based on 1 article reviews
promis— physical function—short form 20a - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
ProMIS Neurosciences patient-reported outcomes measurement information system questionnaire: physical function-short form 20a (promis-20a)
Anchor-based MCIDs for 6MWD (% predicted) for subgroups of patients with baseline 6MWD < 150 m, < 300 m, < 400 m, < 450 m, and ≥ 450 m. Abbreviations: 6MWD 6-min walk distance, m meter, FVC forced vital capacity, FVC ≥ 3% MCID based on patients with an FVC (% predicted) change from baseline of ≥ 3% at Week 52, MCID minimal clinically important difference, PROMIS Patient-Reported Outcome Measures Information System, PROMIS ≥ 0 MCID based on patients with a PROMIS Physical Function short form <t>20a</t> (PF) change from baseline of ≥ 0 points at Week 52, PROMIS ≥ 2 MCID based on patients with a PROMIS PF change from baseline of ≥ 2 points at Week 52, PROMIS ≥ 4 MCID based on patients with a PROMIS PF change from baseline of ≥ 4 points at Week 52, SGIC Subject’s Global Impression of Change, SGIC ≥ 4 MCID based on patients with an SGIC of ≥ 4 points at Week 52, SGIC ≥ 5 MCID based on patients with an SGIC of ≥ 5 points at Week 52, SGIC = 4 MCID based on patients with an SGIC of = 4 points at Week 52, SGIC = 5 MCID based on patients with an SGIC of = 5 points
Patient Reported Outcomes Measurement Information System Questionnaire: Physical Function Short Form 20a (Promis 20a), supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/promis%C2%AE+physical+function+short+form+20a/pmc08686851-137-40-44?v=ProMIS+Neurosciences
Average 90 stars, based on 1 article reviews
patient-reported outcomes measurement information system questionnaire: physical function-short form 20a (promis-20a) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Anchor-based MCIDs for 6MWD (% predicted) for subgroups of patients with baseline 6MWD < 150 m, < 300 m, < 400 m, < 450 m, and ≥ 450 m. Abbreviations: 6MWD 6-min walk distance, m meter, FVC forced vital capacity, FVC ≥ 3% MCID based on patients with an FVC (% predicted) change from baseline of ≥ 3% at Week 52, MCID minimal clinically important difference, PROMIS Patient-Reported Outcome Measures Information System, PROMIS ≥ 0 MCID based on patients with a PROMIS Physical Function short form 20a (PF) change from baseline of ≥ 0 points at Week 52, PROMIS ≥ 2 MCID based on patients with a PROMIS PF change from baseline of ≥ 2 points at Week 52, PROMIS ≥ 4 MCID based on patients with a PROMIS PF change from baseline of ≥ 4 points at Week 52, SGIC Subject’s Global Impression of Change, SGIC ≥ 4 MCID based on patients with an SGIC of ≥ 4 points at Week 52, SGIC ≥ 5 MCID based on patients with an SGIC of ≥ 5 points at Week 52, SGIC = 4 MCID based on patients with an SGIC of = 4 points at Week 52, SGIC = 5 MCID based on patients with an SGIC of = 5 points

Journal: Orphanet Journal of Rare Diseases

Article Title: Minimal clinically important differences in six-minute walking distance in late-onset Pompe disease

doi: 10.1186/s13023-024-03156-3

Figure Lengend Snippet: Anchor-based MCIDs for 6MWD (% predicted) for subgroups of patients with baseline 6MWD < 150 m, < 300 m, < 400 m, < 450 m, and ≥ 450 m. Abbreviations: 6MWD 6-min walk distance, m meter, FVC forced vital capacity, FVC ≥ 3% MCID based on patients with an FVC (% predicted) change from baseline of ≥ 3% at Week 52, MCID minimal clinically important difference, PROMIS Patient-Reported Outcome Measures Information System, PROMIS ≥ 0 MCID based on patients with a PROMIS Physical Function short form 20a (PF) change from baseline of ≥ 0 points at Week 52, PROMIS ≥ 2 MCID based on patients with a PROMIS PF change from baseline of ≥ 2 points at Week 52, PROMIS ≥ 4 MCID based on patients with a PROMIS PF change from baseline of ≥ 4 points at Week 52, SGIC Subject’s Global Impression of Change, SGIC ≥ 4 MCID based on patients with an SGIC of ≥ 4 points at Week 52, SGIC ≥ 5 MCID based on patients with an SGIC of ≥ 5 points at Week 52, SGIC = 4 MCID based on patients with an SGIC of = 4 points at Week 52, SGIC = 5 MCID based on patients with an SGIC of = 5 points

Article Snippet: In this study, answers were grouped into 3 categories: improving (patient scored ‘somewhat improved’, ‘much improved’, or ‘very much improved’); stable (patient scored ‘no change’); or declining (patient scored ‘somewhat worse’, ‘much worse’, or ‘very much worse’). (v) PROMIS® Physical Function short form 20a [ , ]: (PROMIS PF): This score is obtained after the patient completes a questionnaire with 20 questions on physical function, which the patient can score from unable to do (1) to be able to do without any difficulties or limitations (5).

Techniques: